Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
BMC Psychiatry ; 23(1): 750, 2023 10 13.
Artigo em Inglês | MEDLINE | ID: mdl-37833705

RESUMO

BACKGROUND: This case report is of a patient with psychosis secondary to thyrotoxicosis that persisted and reemerged after definitive treatment of thyroidectomy, which is a unique occurrence in the literature. CASE PRESENTATION: This patient is a male between 30 and 35 years of age with a history of Graves Disease and no past psychiatric history who was admitted to the hospital due to psychosis secondary to thyrotoxicosis. The thyrotoxicosis was treated with surgical removal, but the psychotic symptoms persisted after surgery and normalization of standard thyroid functional measures. The symptoms were of sufficient significance for inpatient psychiatric hospitalization, a rare occurrence. Ultimately after an extended stay in the psychiatric unit, the patient's symptoms stabilized with a second-generation antipsychotic, and the patient was discharged from the psychiatric unit. CONCLUSION: This case is evidence that the link between psychosis and hyperthyroidism is still poorly understood due to the patient's psychotic symptoms persisting after the definitive treatment of thyroidectomy and the fact that it required anti-psychotic medications for normalization.


Assuntos
Doença de Graves , Transtornos Psicóticos , Tireotoxicose , Masculino , Humanos , Tireoidectomia/efeitos adversos , Tireotoxicose/complicações , Tireotoxicose/cirurgia , Doença de Graves/complicações , Doença de Graves/cirurgia , Doença de Graves/tratamento farmacológico , Transtornos Psicóticos/complicações
2.
J Opioid Manag ; 16(5): 391-394, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-33226096

RESUMO

Kratom (Mitragyna speciosa) is a plant extract that exhibits opioid agonistic activity at the µ-opioid receptor. The use of this substance has increased recently due to widespread local availability across the United States, primarily at gas stations. Repeated kratom use has been shown to have major adverse effects leading to physiological dependence and addiction similar to other opioids. We used a novel contingency management (CM) program utilizing nonmonetary reinforcers along with medication-assisted treatment (MAT) using buprenorphine in an office-based setting to treat kratom use disorder in two cases. MAT with buprenorphine in a CM-based setting was found to be an effective strategy for treating kratom use disorder.


Assuntos
Analgésicos Opioides/uso terapêutico , Buprenorfina/uso terapêutico , Mitragyna/química , Transtornos Relacionados ao Uso de Substâncias/tratamento farmacológico , Analgésicos Opioides/administração & dosagem , Humanos , Tratamento de Substituição de Opiáceos/métodos , Estados Unidos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...